Who are Cellular Matrix / A-CP-HA Kit's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Autologous platelets rich plasma, Low-dose PRP, Leukocyte rich platelet rich plasma, ACP, Bone marrow aspirate matrix.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cellular-matrix-a-cp-ha-kit.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Cellular Matrix / A-CP-HA Kit — Competitive Intelligence Brief

Cellular Matrix / A-CP-HA Kit (Cellular Matrix / A-CP-HA Kit) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cell therapy / Regenerative medicine product. Area: Regenerative Medicine / Orthopedics.

marketed Cell therapy / Regenerative medicine product Regenerative Medicine / Orthopedics Small molecule Live · refreshed every 30 min

Target snapshot

Cellular Matrix / A-CP-HA Kit (Cellular Matrix / A-CP-HA Kit) — Fundación Santiago Dexeus Font. A cellular matrix product combining autologous cells with hyaluronic acid to promote tissue regeneration and repair.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Cellular Matrix / A-CP-HA Kit TARGET	Cellular Matrix / A-CP-HA Kit	Fundación Santiago Dexeus Font	marketed	Cell therapy / Regenerative medicine product
Autologous platelets rich plasma	Autologous platelets rich plasma	Mostafa Hassanein, Msc	marketed	Autologous cell therapy / Regenerative medicine product
Low-dose PRP	Low-dose PRP	Hospital for Special Surgery, New York	marketed	Autologous cell therapy / Regenerative medicine product
Leukocyte rich platelet rich plasma	Leukocyte rich platelet rich plasma	University Hospitals Cleveland Medical Center	marketed	Autologous cell therapy / Regenerative medicine product
ACP	ACP	Istituto Ortopedico Rizzoli	marketed	Cell therapy / Regenerative medicine product
Bone marrow aspirate matrix	Bone marrow aspirate matrix	Instituto Nacional de Traumatologia e Ortopedia	phase 3	Cell therapy / Regenerative medicine product

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cell therapy / Regenerative medicine product class)

Fundación Santiago Dexeus Font · 1 drug in this class
Instituto Nacional de Traumatologia e Ortopedia · 1 drug in this class
Istituto Ortopedico Rizzoli · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cellular Matrix / A-CP-HA Kit — Competitive Intelligence Brief. https://druglandscape.com/ci/cellular-matrix-a-cp-ha-kit. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab